comparemela.com

Latest Breaking News On - Prevention framework - Page 11 : comparemela.com

FDA Approves Extended-Release Injection for Opioid Use Disorder

TUESDAY, May 30, 2023 (HealthDay News) The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat moderate-to-severe opioid use disorder.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.